Press Releases

 Filter by Provider

The DJS Law Group announces that it is investigating claims on behalf of investors of F5, Inc. (“F5” or “the Company”) (NASDAQ: FFIV) for violations of the securities laws.

The DJS Law Group announces that it is investigating claims on behalf of investors of Freshpet, Inc. (“Freshpet” or “the Company”) (NASDAQ: FRPT) for violations of the securities laws.

Hartgraves & the Adventure in Time!

Incyte (Nasdaq:INCY) announced the first clinical data evaluating its TGFβR2×PD-1 bispecific antibody (INCA33890) for patients with microsatellite stable (MSS) colorectal cancer; and its potent, selective and orally bioavailable KRAS G12D inhibitor (INCB161734) for patients with KRAS G12D mutations, specifically pancreatic ductal adenocarcinoma (PDAC). The data were featured in two oral sessions (Investigational immunotherapy; Abstract #1522MO and Developmental therapeutics; Abstract #916O, respectively) at the European Society of Medical Oncology (ESMO) Congress 2025.

London, UK – October 15, 2025 – In response to the growing threat of online fraud, Amdark Limited, a leading financial forensics and scam recovery firm, is proud to announce the expansion of its crypto scam recovery services worldwide, with a focused effort on tackling investment scams in Canada, as well as bolstering scam recovery initiatives across the UK and USA.

Cebuana, now based in Donostia–San Sebastián, Patricia Kyle Mendoza brings humor, intensity, and emotional precision (or lack thereof) to ARTfair Innsbruck 2025. Exhibiting with Madrid’s MONAT Gallery from 24–26 October 2025 at Olympiaworld Innsbruck. Her works, Mixed Feelings: From Mojito Mayhem and To Rum Rampage, spout stories of self-control, indulgence, and the morning after-–paintings that slip between abstraction and confession.

New York State’s “OTW Ventures” buys property in Deming, New Mexico located in Luna County. Town and Country supported this buy, losing leg on charitable foundations in communities drove that participation. There were other markets after losing connection with their Colorado listing agent such as, Massachusetts, Georgia and New Jersey. Investors Hedera, Massport and NYPD 45th Precinct provide insight on this development. Bronx Borough President Venessa L. Gibson will be a spotlight and the spark of up and coming brands from NYC. “Gibson’s”, NYC is an entertaining zone if we want precision, if we want leisure and recreation Gibson’s NYC provides the same precision. Borough President Gibson is also working closely with the New York State Department of Labor to create pathways to employment for job seekers across the borough. By connecting residents with job opportunities and providing workforce development resources, she aims to reduce unemployment and help individuals build sustainable careers. She also collaborates with the Bronx Economic Development Corporation to offer financial support to struggling businesses, helping them recover and flourish in a post-pandemic economy. Through her leadership and tireless commitment to the Bronx, Borough President Vanessa L. Gibson continues to shape a brighter future for the borough and its residents. OTW Ventures L.L.C is offering commissions + daily stipend to licensed drivers interested in joining their NYC lobby. Drivers will commute throughout their assigned boroughs offering OTW Ventures L.L.C for its lobbying services, gained clients will employed residents constant commission added to the quality of a varying stipend employees will receive. Employed residents will be trained and equipped with the necessary skills and tools required to “substantiate success”, there are always new businesses starting in the city which anchor opportunity.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of F5, Inc. (“F5” or “the Company”) (NASDAQ: FFIV) for violations of the securities laws.

As the world accelerates toward digital transformation, LiquidiumX emerges as a global blockchain-powered platform revolutionising cross-border collaboration, crypto innovation, and digital finance. By merging artificial intelligence (AI), blockchain technology, and cloud infrastructure, LiquidiumX is creating a globally connected ecosystem where users, developers, and enterprises can thrive without geographical limitations.

NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) --

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Freshpet, Inc. (“Freshpet” or “the Company”) (NASDAQ: FRPT) for violations of the securities laws.

Lakeshore Biopharmaceuticals Co., Ltd. (formerly known as Yisheng Biopharmaceuticals Co., Ltd., hereinafter referred to as the "Company") is a global company dedicated to the discovery, development, manufacturing, and delivery of next-generation vaccines and therapeutic biologics for infectious diseases and cancer. Founded by Mr. Zhang Yi, the Company's stock began trading on the Nasdaq Stock Exchange on March 17, 2023, under the ticker symbol "YS." Following the company's name change in May 2024, the ticker symbol was changed to "LSB." On December 9, 2023, the then-current Board of Directors voted to remove Mr. Zhang Yi from the position of Chairman. The Company announced this event on December 12, 2023.

NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) --

Tulum, Mexico The future of holistic recovery has arrived. Nestled along the turquoise coastline of Tulum, a groundbreaking luxury rehab and ibogaine treatment center is setting a new global standard for safe, legal, and life-changing healing experiences. Designed for those seeking true transformation, this oceanfront sanctuary combines world-class medical care with spiritual depth — offering both ibogaine treatment and ayahuasca retreats in one integrated healing environment.

American Airlines, Citi and Mastercard today unveiled the Citi® / AAdvantage® Globe™ Mastercard®—a new entry in the travel credit card market that reimagines what mid-tier means with access to premium benefits. Designed to maximize the travel journey, the Citi® / AAdvantage® Globe™ Mastercard® offers four Admirals Club® Globe™ passes, each valid for 24 hours; more opportunities to earn AAdvantage® miles and Loyalty Points toward status, including a first-of-its-kind Flight Streak™ bonus; and over $750 in valuable travel and lifestyle benefits—all for an annual fee of $3501.

TORONTO, Oct. 19, 2025 (GLOBE NEWSWIRE) --  Rockcliffe Labs Inc. (“Rockcliffe Labs”), a Canadian biotechnology venture creation platform, announces the launch of its first dedicated program designed to transform breakthrough scientific discoveries into scalable companies. This launch establishes Rockcliffe Labs as the first institution of its kind in Canada, with a mandate to create 100 biotechnology and life sciences ventures over the next decade.

RADNOR, PA - October 19, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) is currently investigating potential violations of the federal securities laws on behalf of investors of F5, Inc. ( NASDAQ: FFIV ) (“F5”).

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Denver, USA, October 19, 2025 -- October 10th, 2025 – NGY Football, a leading global smart sports investment platform, has announced that its registered user base has officially surpassed 6 million. This milestone marks a significant achievement, as the platform has rapidly evolved from an emerging player to a key participant in the industry within just a few years. Along with its swift user growth, NGY Football has consistently strengthened its technical research and development, security measures, and market expansion efforts, further solidifying its competitive edge in the global sports investment field.

RADNOR, PA - October 19, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. (“Lantheus”) ( NASDAQ: LNTH ) on behalf of those who purchased or otherwise acquired Lantheus securities between February 26, 2025, and August 5, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is November 10, 2025.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

SaaSpedia is the #1 AI SEO agency for SaaS founders and startups. We help 120+ AI-driven brands get cited and trusted across ChatGPT, Gemini, Perplexity, and Google by mastering AEO, GEO, and LLM SEO. Backed by 3M+ GPT chats and 1.2M+ visitors, we turn SaaS websites into authority sources AI loves to recommend.

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced results from the Phase III HARMONi-6 trial, conducted in China and sponsored by our partner, Akeso, Inc. (HKEX Code: 9926.HK), featuring the novel, potential first-in-class investigational bispecific antibody, ivonescimab. The data was presented today as part of the Presidential Symposium at the European Society for Medical Oncology 2025 Congress (ESMO 2025) in Berlin, Germany.

RADNOR, PA - October 19, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Fortinet, Inc. (“Fortinet”) ( NASDAQ: FTNT ) on behalf of those who purchased or otherwise acquired Fortinet common stock between November 8, 2024, and August 6, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is November 21, 2025.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

RADNOR, PA - October 19, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina”) ( NYSE: MOH ) on behalf of those who purchased or otherwise acquired Molina securities between February 5, 2025, and July 23, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is December 2, 2025.

IGOTIN, the Rapid Campus Takeover App. Empowering Connection, Collaboration, and Community.

Median progression free survival (PFS) has not been reached in the cohort of patients with salivary gland cancer with PFS follow up suggesting a more than doubling of the benchmark PFS and a disease control rate of 91%

From real homeowner pain points to daily comfort: human-centered engineering, motorized pergola controls, AAMA 2605 powder coating, and made-to-fit customization make luxury pergola features attainable.

Initial results from the dose escalation part of the first-in-human phase 1/2 trial of DS-3939 demonstrated promising clinical activity in patients with previously treated advanced solid tumors refractory to standard treatment. These data were presented today during a proffered paper session (917O) at the 2025 European Society for Medical Oncology (#ESMO25).

Study finds Skechers Arch Fit 2.0 superior to ASICS for senior walking shoes, offering better support at lower prices. Findings align with Healthfit Publishing's 49-day walking program designed for seniors with joint concerns.

Results from the phase 2 (dose optimization) part of the REJOICE-Ovarian01 phase 2/3 trial showed that raludotatug deruxtecan (R-DXd) demonstrated clinically meaningful response rates in patients with recurrent platinum-resistant ovarian, primary peritoneal or fallopian tube cancer. These data were presented today during a late-breaking proffered paper session (LBA42) at the 2025 European Society for Medical Oncology (#ESMO25) Congress.

Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations across HIV, respiratory viruses, viral hepatitis, and viruses of pandemic potential including six oral presentations underscore Gilead’s leadership in advancing antiviral science and its ongoing efforts to bring forward innovative solutions for people and communities most affected by infectious diseases.

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, October 19-22, 2025, in Atlanta, GA. The details of the presentations are as follows:

SOUTH SAN FRANCISCO, Calif., Oct. 19, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that the Company plans to report topline data from the Phase 2 clinical trial of RPT904 (JYB1904) in patients with Chronic Spontaneous Urticaria (CSU) conducted by its partner, Shanghai Jeyou Pharmaceutical Co., Ltd. (Jeyou), formerly called Shanghai Jemincare Pharmaceutical Co., Ltd., in a premarket press release and webcast on Monday, October 20, 2025.RAPT will host a webcast conference call accompanied by a slide presentation on Monday, October 20, 2025 at 8:30 a.m. ET. To join the conference call via phone and participate in the live Q&A session, please pre-register online here to receive a telephone number and unique passcode required to enter the call. The live webcast and audio archive of the presentation may be accessed on the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

WOBURN, Mass., Oct. 19, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced data from a new ad hoc analysis from the IGNYTE phase 2 cohort of RP1 plus nivolumab was presented by Caroline Robert, M.D., Ph.D., at the European Society for Medical Oncology (ESMO) Congress 2025 being held in Berlin (Poster 1644P).

Interviews with fifty failed startup managers reveal that most collapses stemmed from weak leadership, not poor ideas. The findings highlight seven recurring management mistakes and emphasize that effective leadership is a learned skill, essential for building clarity, trust, and lasting team success.

BlockWoods is a leading Crypto Marketing agency with creative marketing experts to scale your business. Join hands with us to emerge as an iconic brand.

This thrilling first-person murder mystery by the author of two Amazon #1 best-sellers is written in past tense - but is set in the future at America’s Sestercentennial.

Dubai, UAE, October 19, 2025 -- ChillPlay Games today announced a significant milestone for its mobile title Over Hit: Hero Fight, which has surpassed 50,000 downloads on Google Play. Coinciding with this momentum, the studio released a major technical update that rebuilds the game from the ground up on a modular engine architecture based on Unity 6 and debuts AI Node, a new in-house module currently in beta. AI Node is powered by Claude AI by Anthropic and leverages the Model Context Protocol (MCP) during the game assembly process to deliver smarter enemies and more coherent level design.

Positive results from the TROPION-Breast02 Phase III trial showed DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival (OS) and progression-free survival (PFS) compared to investigator's choice of chemotherapy as 1st-line treatment for patients with locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC) for whom immunotherapy was not an option.

Owen Hanson, a former University of Southern California football player who received a 21-year federal sentence for drug trafficking, has launched a new website to share his redemption story and provide resources for people seeking to rebuild their lives.

Tanjong Malim, home to Proton Cars and upcoming BYD EV production, is adding a world-class AI-powered data centre at Sungai Samak Estate. This Malaysia Data Centre project supports Southeast Asia’s manufacturing growth, sustainability goals, and hyperscaler ambitions—offering unrivalled efficiency, connectivity, and expansion potential.

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today shared new late-breaking data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the European Society for Medical Oncology (ESMO) 2025 Annual Meeting. The data demonstrated a progression-free survival (PFS) benefit for patients who experienced disease progression while on or after taking a PARP inhibitor (PARPi), a patient population with particularly poor prognosis. The presentation slides can be found here. The company also announced expansion of the Phase 2 BELLA trial in a poster session at ESMO, found here.

São Paulo / New York, 2025 — As a global asset management firm committed to bridging traditional finance and the digital future, Chainvest Gestora de Recursos Ltda. is driving the compliant development and inclusive adoption of blockchain finance and digital asset management across Latin America. At the heart of this mission stand two key leaders — João Pedro and Mariana Silva — whose extensive international investment banking and digital asset management experience form the strategic core of Chainvest’s global growth.